as on November 7, 2025 at 4:01 pm IST
Day's Low
1.62%
Downside
52 Week's Low
52 Week's High
27.92%
Downside
5.50%
Upside
as on November 7, 2025 at 4:01 pm IST
Market Cap
₹354.14 Cr
Return on Equity (ROE)
22.04
PE Ratio (TTM)
21.95
Return on capital employed (ROCE)
27.61
Industry PE ratio
41.8
Beta (LTM)
0.13
P/B Ratio
4.5
Dividend Yield
0PEG Ratio
2.71
Quarterly Earnings Growth YOY
73.75
EPS (TTM)
9.13
Sector
Pharmaceuticals
Book Value
56.05
Technical Analysis
Bullish
View Technical Analysis
as on November 7, 2025 at 4:01 pm IST
Trident Lifeline Ltd in the last 5 years
Lowest (6.24x)
January 9, 2023
Today (21.95x)
November 7, 2025
Industry (41.80x)
November 7, 2025
Highest (57.39x)
September 5, 2024
Today’s Price to Earnings Ratio: 21.95x
Compare market cap, revenue, PE, and other key metrics of Trident Lifeline Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 354.14 | 36.5% | 0.74 | 10 | 86 | |
| BUY | 3,474.21 | -0.13% | 0.53 | 133 | 636 | |
| NA | 17.40 | 121.46% | 0.00 | NA | NA | |
| NA | 1,362.63 | -1.78% | 0.74 | 28 | 311 | |
| NA | 2,052.79 | 6.4% | 0.00 | 100 | 390 |
Search interest for Trident Lifeline Ltd Stock has increased by 37% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:37% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Trident Lifeline Ltd.
Trident Lifeline Ltd’s net profit jumped 33.62% since last year same period to ₹3.06Cr in the Q1 2025-2026. On a quarterly growth basis, Trident Lifeline Ltd has generated -56.72% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, Trident Lifeline stock has moved up by 2.0%
Best in 3 Years
![]()
In the last 3 years, Trident Lifeline has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Up
![]()
Promoters have increased holdings from 63.04% to 63.11% in Sep 2025 quarter
FII Holding Up
![]()
Foreign Institutions have increased holdings from 7.21% to 7.71% in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Divis Laboratories Ltd has given 15.5% return, outperforming this stock by 14.3%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 7.07 Cr → 3.06 Cr (in ₹), with an average decrease of 56.7% per quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 29.36% to 28.78% in Sep 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 35.88 Cr → 24.96 Cr (in ₹), with an average decrease of 30.4% per quarter
| Organisation | Trident Lifeline Ltd |
| Headquarters | Surat |
| Industry | Pharmaceuticals |
| CEO | Hardik J Desai |
| E-voting on shares | Click here to vote |
Trident Lifeline Ltd share price today stands at ₹308 as on at the close of the market. Trident Lifeline Ltd share today touched a day high of ₹308 and a low of ₹303.
Trident Lifeline Ltd touched a 52 week high of ₹324.95 and a 52 week low of ₹222. Trident Lifeline Ltd share price today i.e. is closed at ₹308, which is -5.22% down from its 52 week high and 38.74% up from its 52 week low.
Trident Lifeline Ltd market capitalisation is ₹354.14 Cr as on .
To buy Trident Lifeline Ltd shares, you need to follow these steps:
Trident Lifeline Ltd trading volume is 1,200.00 as on . This means that 1,200.00 shares of Trident Lifeline Ltd were bought and sold on the stock market during today's trading session.